Recent Updates
Recently added Catalysts

external Responsive Neurostimulator System

Phase 2

Epilepsy | Unknown | Neurology |Neuropace, Inc.|Last Updated: Aug 26, 2010

Success Probability
Subscribe to view
Market & Valuation
Subscribe to view
Trial Design
UNCONTROLLED
Total Trials1
Total Enrollment150
FDA Designations
No designations recorded
Clinical trial landscape

external Responsive Neurostimulator System · 1 trial · 1 indication

Phase 2 1
NCT00158067Study of an External Responsive Neurostimulator System on Epileptiform ActivityEpilepsy
COMPLETED150 Analytics
PHASE2COMPLETED
Study of an External Responsive Neurostimulator System on Epileptiform Activity
EpilepsyUnlock trial analytics
Study Design & Arms
AllocationNON_RANDOMIZED
MaskingNONE
ModelSINGLE_GROUP
PurposeTREATMENT
Interventions
NameTypeDescription
external Responsive Neurostimulator (eRNS) SystemDEVICE -
Unlock Study Design Details
Eligibility Criteria
Age Range12 Years to N/A
SexALL
Healthy VolunteersNo
Study Sites5

Inclusion Criteria: * Subject is undergoing evaluation for epilepsy surgery in a manner consistent with the Surgery for Epilepsy, NIH Consensus Statement, 1990 Mar 19-21; 8(2); 1-20. * Subject is implanted with intracranial electrodes. * Subject is under constant medical supervision while implanted...

Countries:United States
Unlock Eligibility Criteria